SCHEMBL11288183

SCHEMBL11288183

CC(C)CC1OC2(CCN(CCc3c[nH]c4ccccc34)CC2)CNC1=O

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.48
DRD3 P35462 2/20 0.44
HTR1A P08908 2/20 0.43
DRD2 P14416 4/20 0.43
DRD4 P21917 1/20 0.43
SLC6A4 P31645 1/20 0.43
HRH1 P35367 1/20 0.43
HTR2B P41595 1/20 0.43
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
TACR2 P21452 1/20 0.42
TACR1 P25103 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11289963 0.90 HTR2A (0.51) HTR2ADRD3HTR1ADRD2DRD4
Hydrochloric Acid SCHEMBL11281215 0.89 HTR2A (0.50) HTR2ADRD3HTR1ADRD2DRD4
SCHEMBL11280929 0.86 HTR2A (0.53) HTR2ADRD3HTR1ADRD2DRD4
Hydrochloric Acid SCHEMBL11284052 0.85 HTR2A (0.52) HTR2ADRD3HTR1ADRD2DRD4
SCHEMBL11277989 0.83 LMNA (0.60) ADRA2A
SCHEMBL11361104 0.79 LMNA (0.63) HTR2ADRD3HTR1ADRD2DRD4
Hydrochloric Acid SCHEMBL11361513 0.78 MAPT (0.64) HTR2ADRD3HTR1ADRD2DRD4
SCHEMBL11021273 0.77 HTR2A (0.56) HTR2ADRD3HTR1ADRD2DRD4
SCHEMBL11275448 0.77 SIGMAR1 (0.67) HTR2ADRD3HTR1ATACR2TACR1
SCHEMBL11282845 0.76 SIGMAR1 (0.67) HTR2ADRD3HTR1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0061333-A1 9-(2-(3-Indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones SYNTEX (U.S.A.) INC. (US) 1982-09-29 EP disclosed
US-4332804-A TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIA, MIGRAINE, VASOSPASTIC DISORDERS AND ASTHMA SYNTEX (U.S.A.) INC. (US) 1982-06-01 US disclosed